Russian vaccine did not complete third phase of clinical trials

Jordan

Published: 2020-08-13 11:59

Last Updated: 2024-04-19 10:57


Russian vaccine did not complete third phase of clinical trials
Russian vaccine did not complete third phase of clinical trials

The health situation in Jordan is stable and much better than any other country in the region, said Wael Al Hajayneh, a member of the National Epidemiology Committee and the official overseeing the coronavirus response in the northern governorate.

“Despite the increasing number of local cases over the past few days, we are still the least-affected country in the region by the coronavirus and therefore the health situation is stable, even if it is concerning, knowing that new cases are expected to be recorded,” said
Hajayneh.

“The cases which were recorded over the past few days follow a certain path for those in contact. Therefore, we have become clearly aware of the source that resulted in the increase of cases in which the closure of the Jaber Border Crossing was a sound decision to ensure that no outbreaks take place.”

Hajayneh said the coronavirus has not ended in light of the increasing cases globally, indicating that winter is fast-approaching with influenza and coronavirus. He added that some people still believe the virus is a conspiracy instead of shifting their behaviours to adapt.

Regarding the recently announced Russian vaccine, Hajayneh said the vaccine consists of two doses and contains two viruses that are equipped in a way where humans are not infected as the installed genetic material sends immunity to its receiver- following an advanced scientific technique, which is promising.

Referencing the recently announced Russian vaccine, Hajayneh said the vaccine consists of two doses.

“What is striking is that the Russian President, Vladimir Putin announced the vaccine and registered it before completing the third phase of clinical trials, which is the most important phase in determining the effectiveness of a vaccine to induce immunity among people resulting in the absence of a disease,” he said.

“It is quite early to speak of its effectiveness, especially that those who have been tested for the vaccine are a few people, compared to the number of those who must be tested.”